The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis

NCT04789837 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional and funding constrains

Conditions

Osteoarthritis

Interventions

DRUG: Cilostazol 50 MG
DRUG: Placebo

Sponsor

Sadat City University